Form 4 for AVTR Avantor, Inc.
Accepted 2024-06-25 00:00:00 ET · period of report 2024-06-21 · accession 0001722482-24-000131 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-25 | 2024-06-21 | AVTR | Walker Corey | Pres Laboratory Solutions | A - Grant | $0.00 | +28.3K | 28.3K | New | $0 |
| D | 2024-06-25 | 2024-06-21 | AVTR | Walker Corey | Pres Laboratory Solutions | A - Grant | $0.00 | +70.5K | 70.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-21 | A | A | 28,254 | $0.00 | 28,254 | D | — | — | |
| 2 | Derivative | Stock Options (Right to Buy) | 2024-06-21 | A | A | 70,462 | $0.00 | 70,462 | D | $22.12 · — to 2034-06-21 | 70,462 Common Stock | (F2) Reflects a grant of stock options that vest in three equal annual installments beginning on June 21, 2025. |